While the challenges posed by the COVID-19 pandemic are massive, so are the good examples of corporate citizenship arising all over the world. Learn more.
fighting pet parasites with holistic approach france
When animals are healthy, humans are healthier, too. This is especially true for parasitic diseases that affect our pets to whom we are close. Read more.
Plastic pollution is one of the most serious threats to the world’s oceans. Click here to find out how long it takes for garbage to dissolve in the oceans!
Colleagues across Canada are doing their part during the pandemic by supporting their community’s needs. Click here to find out and learn more information.
As a global leader in poultry disease prevention, Boehringer Ingelheim gathered more than 500 leaders in the global poultry industry in Prague. Learn more.
The Riding for the Disabled Association (RDA) provides therapy, achievement and enjoyment to people with disabilities all over the UK. Learn more here.
Early August 2018, NexGard Spectra (afoxolaner and milbemycin oxime), the first oral endectocide for dogs, was launched in China. Click here to learn more.
Development Biotechnology sustainable cell culture
Boehringer Ingelheim refines its bioprocess technology operations in Animal Health with greater focus on environmental sustainability to reduce footprint.
The ecological balance of the world is at a tipping point. Thus, we step up the initiative “Carbon Footprint”. Click here to find out more information.
Shanghai serves as an important hub for all of the company’s three business areas: Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing.
Click here to find out how Boehringer Ingelheim is working to improve the sustainability and biodiversity of the research site at Saint-Vulbas in France.
Online training options develop vets and other animal health professionals’ skills helping them overcome movement restrictions to thrive around the globe.